Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19
인터페론 경로 루푸스 위험 대립 유전자는 급성 COVID-19로 인한 사망 위험을 조절합니다
Article
Published on
Journal: Translational research : the journal of laboratory [Category] 바이오마커, 변종, 유전자 메커니즘, 치료제,
Journal: Translational research : the journal of laboratory [Category] 바이오마커, 변종, 유전자 메커니즘, 치료제,
[키워드] Activation
activator
acute COVID-19
age
allele
alleles
analyzed
antiviral immunity
Biomarker
Blood
BMI = body mass index
body mass
body mass index
C-reactive protein
cGMP
contribute
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 = coronavirus disease 2019
Critical
CRP = C-reactive protein
D-dimer
death
Defense
disease
domain
Effect
gain-of-function
Genetic
genetic information
genetic risk factor
Genotype
groups
Haplotype
Helicase
high risk
idea
IFIH1
IFIH1 = interferon-induced with helicase c domain 1
IFN
IFN = interferon
IFN pathway
Increased
interferon
interferon regulatory factor
IRF = interferon regulatory factor
IRF5
IRF7
IRF8
lupus erythematosus
modulate
Mortality
nucleotide
NYU = New York University
older subjects
OR = odds ratio
pathway
Patient
positive
Predictive
Primary outcome
PRKG1
PRKG1 = protein kinase cGMP-dependent 1
protective effect
Protective effects
Protein
protein kinase
Regulatory
risk
risk allele
risk factor
risk of death
significantly
Single nucleotide polymorphism
SLE
SLE = systemic lupus erythematosus
SNP = single nucleotide polymorphism
STAT4
STAT4 = signal transducer and activator of transcription 4.
subjects
Support
systemic lupus erythematosus
Transcription
troponin
Type
Type I IFN
type I interferon
variants
viral infections
York
younger patient
younger patients
[DOI] 10.1016/j.trsl.2022.01.007 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.trsl.2022.01.007 PMC 바로가기 [Article Type] Article